ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
ESG
ESG Management
Archive
CONTACT
INVESTORS
[비즈워치] 국내 첫 CAR-T 개발 성큼…큐로셀, ‘넥스트 스텝’은
2024/03/18
국내 첫 CAR-T 개발 성큼…큐로셀, ‘넥스트 스텝’은 (bizwatch.co.kr)
Prev
[이코노미스트] 국산 CAR-T 치료제로 한 걸음…큐로셀의 상업화 계획은[임상이몽]
Next
[MTN] [점프업바이오] 큐로셀, ‘안발셀’ 임상서 효능 입증…”올해 품목허가 목표”
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.